Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: The Rancho Bernardo Study

Clinical Endocrinology

Volumn 65, Issue 4, 2006, Pages 506-513

  Laughlin, Gail A ^a   Barrett Connor, Elizabeth ^a   May, Susanne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; ESTRADIOL; ESTROGEN; INSULIN; LEPTIN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

ADIPONECTIN; ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HUMANS; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; TESTOSTERONE;

EID: 33748795552     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02624.x     Document Type: Article

References (53)

1. Fasshauer, M., Paschke, R. & Stumvoll, M. (2004) Adiponectin, obesity, and cardiovascular disease. Biochimie, 86, 779-784.
2. Peelman, F., Waelput, W., Iserentant, H., Lavens, D., Eyckerman, S., Zabeau, L. & Tavernier, J. (2004) Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Progress in Lipid Research, 43, 283-301.
3. Wajchenberg, B.L. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews, 21, 697-738.
4. Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D. & Kahn, S.E. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46, 459-469.
5. Kwon, K., Jung, S.H., Choi, C. & Park, S.H. (2005) Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. International Journal of Cardiology, 101, 385-390.
6. Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R. & Ranganathan, S. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine, 1, 1155-1161.
7. Dieudonne, M.N., Pecquery, R., Leneveu, M.C. & Giudicelli, Y. (2000) Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology, 141, 649-656.
8. Dieudonne, M.N., Leneveu, M.C., Giudicelli, Y. & Pecquery, R. (2004) Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. American Journal of Physiology-Cell Physiology, 286, C655-C661.
9. Dieudonne, M.N., Pecquery, R., Boumediene, A., Leneveu, M.C. & Giudicelli, Y. (1998) Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. American Journal of Physiology, 274, C1645-C1652.
10. Panet-Raymond, V., Gottlieb, B., Beitel, L.K., Pinsky, L. & Trifiro, M.A. (2000) Interactions between androgen and estrogen receptors and the effects on their transactivational properties. Molecular Cell Endocrinology, 167, 139-150.
11. Tremblay, R.R. & Dube, J.Y. (1974) Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception, 10, 599-605.
12. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
13. Desbuquois, B. & Aurbach, G.D. (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Journal of Clinical Endocrinology and Metabolism, 33, 732-738.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
15. World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
16. Zamboni, M., Zoico, E., Fantin, F., Panourgia, M.P., Di Francesco, V., Tosoni, P., Solerte, B., Vettor, R. & Bosello, O. (2004) Relation between leptin and the metabolic syndrome in elderly women. Journal of Gerontology Series A: Biological Sciences Medical Sciences, 59, 396-400.
17. Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y. & Funahashi, T. (2004) Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal, 68, 975-981.
18. Soderberg, S., Ahren, B., Jansson, J.H., Johnson, O., Hallmans, G., Asplund, K. & Olsson, T. (1999) Leptin is associated with increased risk of myocardial infarction. Journal of International Medicine, 246, 409-418.
19. Wallace, A.M., McMahon, A.D., Packard, C.J., Kelly, A., Shepherd, J., Gaw, A. & Sattar, N. (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation, 104, 3052-3056.
20. Wolk, R., Berger, P., Lennon, R.J., Brilakis, E.S., Johnson, B.D. & Somers, V.K. (2004) Plasma leptin and prognosis in patients with established coronary atherosclerosis. Journal of the American College of Cardiology, 44, 1819-1824.
21. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B. & Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association, 291, 1730-1737.
22. Goldstein, B.J. & Scalia, R. (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. Journal of Clinical Endocrinology and Metabolism, 89, 2563-2568.
23. Kirschner, M.A., Samojlik, E., Drejka, M., Szmal, E., Schneider, G. & Ertel, N. (1990) Androgen-estrogen metabolism in women with upper body versus lower body obesity. Journal of Clinical Endocrinology and Metabolism, 70, 473-479.
24. Kirschner, M.A. & Samojlik, E. (1991) Sex hormone metabolism in upper and lower body obesity. International Journal of Obesity, 15, 101-108.
25. Kalish, G.M., Barrett-Connor, E., Laughlin, G.A. & Gulanski, B.I. (2003) Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. Journal of Clinical Endocrinology and Metabolism, 88, 1646-1652.
26. Mayes, J.S. & Watson, G.H. (2004) Direct effects of sex steroid hormones on adipose tissues and obesity. Obesity Review, 5, 197-216.
27. Corbould, A.M., Judd, S.J. & Rodgers, R.J. (1998) Expression of types 1, 2, and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. Journal of Clinical Endocrinology and Metabolism, 83, 187-194.
28. Corbould, A.M., Bawden, M.J., Lavranos, T.C., Rodgers, R.J. & Judd, S.J. (2002) The effect of obesity on the ratio of type 3, 17beta-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women. International Journal of Obesity and Related Metabolic Disorders, 26, 165-175.
29. Belanger, C., Luu-The, V., Dupont, P. & Tchernof, A. (2002) Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Hormone and Metabolic Research, 34, 737-745.
30. Rivarola, M.A., Singleton, R.T. & Migeon, C.J. (1967) Splanchnic extraction and interconversion of testosterone and androstenedione in man. Journal of Clinical Investigations, 46, 2095-2100.
31. Cote, M., Mauriege, P., Bergeron, J., Almeras, N., Tremblay, A., Lemieux, I. & Despres, J.P. (2005) Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. Journal of Clinical Endocrinology and Metabolism, 90, 1434-1439.
32. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., Nakamura, T., Tochino, Y., Funahashi, T. & Matsuzawa, Y. (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 51, 2734-2741.
33. Lanfranco, F., Zitzmann, M., Simoni, M. & Nieschlag, E. (2004) Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clinical Endocrinology, 60, 500-507.
34. Page, S.T., Herbst, K.L., Amory, J.K., Coviello, A.D., Anawalt, B.D., Matsumoto, A.M. & Bremner, W.J. (2005) Testosterone administration suppresses adiponectin levels in men. Journal of Andrology, 26, 85-92.
35. Ducluzeau, P.H., Cousin, P., Malvoisin, E., Bornet, H., Vidal, H., Laville, M. & Pugeat, M. (2003) Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88, 3626-3631.
36. Orio, F. Jr., Palomba, S., Cascella, T., Milan, G., Mioni, R., Pagano, C., Zullo, F., Colao, A., Lombardi, G. & Vettor, R. (2003) Adiponectin levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88, 2619-2623.
37. Spranger, J., Mohlig, M., Wegewitz, U., Ristow, M., Pfeiffer, A.F., Schill, T., Schlosser, H.W., Brabant, G. & Schofl, C. (2004) Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology, 61, 738-746.
38. Panidis, D., Kourtis, A., Farmakiotis, D., Mouslech, T., Rousso, D. & Koliakos, G. (2003) Serum adiponectin levels in women with polycystic ovary syndrome. Human Reproduction, 18, 1790-1796.
39. Ardawi, M.S. & Rouzi, A.A. (2005) Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility, 83, 1708-1716.
40. Vrbikova, J., Dvorakova, K., Hill, M., Vcelak, J., Stanicka, S., Vankova, M., Sramkova, D., Vondra, K., Bendlova, B. & Starka, L. (2005) Determinants of circulating adiponectin in women with polycystic ovary syndrome. Gynecologic and Obstetric Investigation, 60, 155-161.
41. Ibanez, L. & de Zegher, F. (2004) Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. Journal of Clinical Endocrinology and Metabolism, 89, 1592-1597.
42. Isobe, T., Saitoh, S., Takagi, S., Takeuchi, H., Chiba, Y., Katoh, N. & Shimamoto, K. (2005) Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. European Journal of Endocrinology, 153, 91-98.
43. Thomas, T., Burguera, B., Melton, L.J. III., Atkinson, E.J., O'Fallon, W.M., Riggs, L. & Khosla, S. (2000) Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism, 49, 1278-1284.
44. Janssen, J.A., Huizenga, N.A., Stolk, R.P., Grobbee, D.E., Pols, H.A., de Jong, H., Attanasio, A.M., Blum, W.F. & Lamberts, S.W. (1998) The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF-I/IGFBP system, dehydroepiandrosterone, androstenedione and testosterone in an elderly population. Clinical Endocrinology, 48, 621-626.
45. Sieminska, L., Marek, B., Kos-Kudla, B., Niedziolka, D., Kajdaniuk, D., Nowak, M. & Glogowska-Szelag, J. (2004) Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. Journal of Endocrinological Investigations, 27, 528-534.
46. Sahin, I., Serter, R., Karakurt, F., Demirbas, B., Guler, S., Culha, C., Taskapan, C. & Aral, Y. (2003) Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome. Hormone Research, 60, 232-236.
47. Gavrila, A., Chan, J.L., Yiannakouris, N., Kontogianni, M., Miller, L.C., Orlova, C. & Mantzoros, C.S. (2003) Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. Journal of Clinical Endocrinology and Metabolism, 88, 4823-4831.
48. Tanko, L.B., Bruun, J.M., Alexandersen, P., Bagger, Y.Z., Richelsen, B., Christiansen, C. & Larsen, P.J. (2004) Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation, 110, 2246-2252.
49. Mendonca, H.C., Montenegro, R.M. Jr, Foss, M.C., Silva de, SaM.F. & Ferriani, R.A. (2004) Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Brazilian Journal of Medical and Biological Research, 37, 729-736.
50. Gavrila, A., Peng, C.K., Chan, J.L., Mietus, J.E., Goldberger, A.L. & Mantzoros, C.S. (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. Journal of Clinical Endocrinology and Metabolism, 88, 2838-2843.
51. Shea, S.A., Hilton, M.F., Orlova, C., Ayers, R.T. & Mantzoros, C.S. (2005) Independent Circadian and Sleep/Wake Regulation of Adipokines and Glucose In Humans. Journal of Clinical Endocrinology and Metabolism.
52. Pischon, T., Hotamisligil, G. & Rimm, E. (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clinical Chemistry, 49, 650-652.
53. Meier, U. & Gressner, A.M. (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry, 50, 1511-1525.